The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination therapy with lenvatinib and anti-PD-1 antibodies for unresectable or advanced hepatocellular carcinoma: A real-world study.
 
Hui-Chuan Sun
Consulting or Advisory Role - Bayer; Eisai; Hengrui Medicine; Innovent Biologics; MSD
 
Xiao-Dong Zhu
No Relationships to Disclose
 
Cheng Huang
No Relationships to Disclose
 
Ying-Hao Shen
No Relationships to Disclose
 
Ning-Ling Ge
No Relationships to Disclose
 
Yi Chen
No Relationships to Disclose
 
Chang-Jun Tan
No Relationships to Disclose
 
Jian Zhou
No Relationships to Disclose
 
Jia Fan
No Relationships to Disclose